NX-1607
A Study of NX-1607 in Adults With Advanced Malignancies Recruiting Status:Recruiting Age:18+ A Phase 1a, Dose Escalation, Safety and Tolerability […]
A Study of NX-1607 in Adults With Advanced Malignancies Recruiting Status:Recruiting Age:18+ A Phase 1a, Dose Escalation, Safety and Tolerability […]
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies Recruiting Status:Recruiting Age:18+ A Phase 1, Dose Escalation, and Cohort
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies Recruiting Status:Recruiting Age:18+ A Phase 1, Dose Escalation, Safety and